Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220.41 USD | -1.40% |
|
-4.45% | -13.13% |
19/07 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
18/07 | Humana loses bid to challenge downgrade to US Medicare 'star' ratings | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.73 | 6.74 | 6.11 | 6.34 | 4.07 | |||||
Return on Total Capital | 15.75 | 10.51 | 9.36 | 10.15 | 6.56 | |||||
Return On Equity % | 26.14 | 19.67 | 17.81 | 15.68 | 7.41 | |||||
Return on Common Equity | 26.14 | 19.68 | 17.88 | 15.77 | 7.4 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 20.12 | 17.81 | 18.5 | 16.9 | 14.52 | |||||
SG&A Margin | 13.03 | 12.02 | 13.13 | 11.87 | 11.22 | |||||
EBITDA Margin % | 6.81 | 5.4 | 4.95 | 4.61 | 2.85 | |||||
EBITA Margin % | 6.58 | 5.17 | 4.7 | 4.36 | 2.63 | |||||
EBIT Margin % | 6.46 | 5.08 | 4.6 | 4.3 | 2.58 | |||||
Income From Continuing Operations Margin % | 4.36 | 3.48 | 3.02 | 2.34 | 1.03 | |||||
Net Income Margin % | 4.36 | 3.48 | 3.02 | 2.34 | 1.02 | |||||
Net Avail. For Common Margin % | 4.36 | 3.48 | 3.02 | 2.34 | 1.02 | |||||
Normalized Net Income Margin | 3.79 | 2.54 | 2.56 | 2.28 | 1.11 | |||||
Levered Free Cash Flow Margin | 2.71 | 0.04 | 4.85 | 0.71 | -1.11 | |||||
Unlevered Free Cash Flow Margin | 2.94 | 0.29 | 5.12 | 1 | -0.76 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.41 | 2.12 | 2.12 | 2.36 | 2.52 | |||||
Fixed Assets Turnover | 29.83 | 25.67 | 24.81 | 29.24 | 36.14 | |||||
Receivables Turnover (Average Receivables) | 67.91 | 54.29 | 50.63 | 55.21 | 47.82 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.77 | 1.62 | 1.52 | 1.59 | 1.76 | |||||
Quick Ratio | 1.48 | 1.33 | 1.32 | 1.36 | 1.37 | |||||
Operating Cash Flow to Current Liabilities | 0.42 | 0.15 | 0.27 | 0.21 | 0.18 | |||||
Days Sales Outstanding (Average Receivables) | 5.39 | 6.72 | 7.21 | 6.61 | 7.65 | |||||
Average Days Payable Outstanding | 64.34 | 64.98 | 65.01 | 64.03 | 58.59 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 54.37 | 84.15 | 78.28 | 77.23 | 76.9 | |||||
Total Debt / Total Capital | 35.22 | 45.7 | 43.91 | 43.58 | 43.47 | |||||
LT Debt/Equity | 46.73 | 68.85 | 61.74 | 65.31 | 70.15 | |||||
Long-Term Debt / Total Capital | 30.27 | 37.39 | 34.63 | 36.85 | 39.65 | |||||
Total Liabilities / Total Assets | 60.74 | 63.7 | 64.3 | 65.33 | 64.62 | |||||
EBIT / Interest Expense | 17.62 | 13.12 | 10.66 | 9.28 | 4.61 | |||||
EBITDA / Interest Expense | 19.25 | 14.59 | 12.03 | 10.35 | 5.38 | |||||
(EBITDA - Capex) / Interest Expense | 15.84 | 10.56 | 9.24 | 8.31 | 4.51 | |||||
Total Debt / EBITDA | 1.37 | 2.85 | 2.49 | 2.47 | 3.56 | |||||
Net Debt / EBITDA | 0.51 | 2.14 | 1.44 | 1.55 | 2.94 | |||||
Total Debt / (EBITDA - Capex) | 1.66 | 3.94 | 3.25 | 3.08 | 4.25 | |||||
Net Debt / (EBITDA - Capex) | 0.62 | 2.95 | 1.88 | 1.93 | 3.51 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 18.9 | 9.12 | 10.31 | 14.54 | 10.7 | |||||
Gross Profit, 1 Yr. Growth % | 40.76 | -3.43 | 14.58 | 4.66 | -4.91 | |||||
EBITDA, 1 Yr. Growth % | 51.28 | -13.41 | 1.01 | 6.73 | -32.14 | |||||
EBITA, 1 Yr. Growth % | 53.34 | -14.27 | 0.44 | 6.23 | -33.65 | |||||
EBIT, 1 Yr. Growth % | 53.94 | -14.22 | -0.09 | 7.04 | -33.99 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 24.38 | -12.86 | -4.5 | -11.35 | -51.13 | |||||
Net Income, 1 Yr. Growth % | 24.38 | -12.89 | -4.33 | -11.3 | -51.51 | |||||
Normalized Net Income, 1 Yr. Growth % | 32.9 | -26.88 | 11.38 | 2.17 | -46.58 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 25.92 | -10.43 | -2.6 | -9.42 | -50.1 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 18.73 | 33.58 | -0.4 | -5.25 | -15.9 | |||||
Accounts Receivable, 1 Yr. Growth % | 7.77 | 59.4 | -7.72 | 21.57 | 32.87 | |||||
Total Assets, 1 Yr. Growth % | 20.28 | 26.85 | -2.94 | 9.31 | -1.25 | |||||
Common Equity, 1 Yr. Growth % | 14.05 | 17.13 | -4.78 | 6.21 | 0.69 | |||||
Tangible Book Value, 1 Yr. Growth % | 12.86 | -73.76 | 87.48 | 13.96 | 5.62 | |||||
Cash From Operations, 1 Yr. Growth % | 6.72 | -59.89 | 102.79 | -13.21 | -25.5 | |||||
Capital Expenditures, 1 Yr. Growth % | 30.98 | 36.51 | -14.89 | -11.7 | -42.73 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -9.85 | -98.22 | 11.96T | -83.08 | -267.57 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -8.21 | -89.38 | 1.87T | -77.48 | -182.38 | |||||
Dividend Per Share, 1 Yr. Growth % | 13.64 | 12 | 12.5 | 12.38 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 16.43 | 13.91 | 9.71 | 13.16 | 12.61 | |||||
Gross Profit, 2 Yr. CAGR % | 18.65 | 16.59 | 5.19 | 13.88 | -0.24 | |||||
EBITDA, 2 Yr. CAGR % | 25.46 | 15.24 | -6.48 | 19.76 | -14.58 | |||||
EBITA, 2 Yr. CAGR % | 26.12 | 15.48 | -7.21 | 20.04 | -15.72 | |||||
EBIT, 2 Yr. CAGR % | 26.58 | 15.75 | -7.43 | 20.54 | -15.61 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 41.44 | 4.11 | -8.78 | -7.99 | -34.18 | |||||
Net Income, 2 Yr. CAGR % | 41.44 | 4.09 | -8.71 | -7.88 | -34.41 | |||||
Normalized Net Income, 2 Yr. CAGR % | 27.57 | -0.76 | -9.76 | 6.68 | -25.78 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 44.27 | 6.2 | -6.6 | -6.07 | -32.77 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 27.22 | 25.94 | 15.35 | -2.85 | -10.73 | |||||
Accounts Receivable, 2 Yr. CAGR % | 5.89 | 31.06 | 21.28 | 5.92 | 27.09 | |||||
Total Assets, 2 Yr. CAGR % | 17.3 | 23.52 | 10.96 | 3.01 | 3.9 | |||||
Common Equity, 2 Yr. CAGR % | 16.23 | 15.58 | 5.61 | 0.56 | 3.42 | |||||
Tangible Book Value, 2 Yr. CAGR % | 21.95 | -45.58 | -29.86 | 46.17 | 9.71 | |||||
Cash From Operations, 2 Yr. CAGR % | 61.09 | -34.57 | -9.81 | 32.66 | -19.59 | |||||
Capital Expenditures, 2 Yr. CAGR % | 25.51 | 33.72 | 7.79 | -13.51 | -28.89 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 167.7 | -87.24 | 46.7 | 4.6 | -45.97 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 281.57 | -68.6 | 44.73 | 47.54 | -56.47 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 12.82 | 12.25 | 12.44 | 6.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.79 | 13.94 | 12.69 | 11.3 | 12.34 | |||||
Gross Profit, 3 Yr. CAGR % | 14.77 | 10.78 | 15.91 | 5.01 | 7.23 | |||||
EBITDA, 3 Yr. CAGR % | 12.66 | 10.87 | 10.29 | -2.27 | -0.66 | |||||
EBITA, 3 Yr. CAGR % | 12.65 | 10.89 | 10.23 | -2.93 | -1.24 | |||||
EBIT, 3 Yr. CAGR % | 12.8 | 11.18 | 10.21 | -2.83 | -1.12 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.21 | 20.35 | 1.16 | -9.64 | -25.48 | |||||
Net Income, 3 Yr. CAGR % | 11.21 | 20.34 | 1.2 | -9.58 | -25.62 | |||||
Normalized Net Income, 3 Yr. CAGR % | 13.09 | 5.97 | 3.13 | -5.94 | -15.03 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.62 | 23.08 | 3.18 | -7.55 | -23.93 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.03 | 29.31 | 16.46 | 8.03 | -7.41 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.04 | 21.35 | 16.6 | 21.38 | 14.23 | |||||
Total Assets, 3 Yr. CAGR % | 8.76 | 20.4 | 13.98 | 10.41 | 1.57 | |||||
Common Equity, 3 Yr. CAGR % | 11.73 | 16.53 | 8.35 | 5.81 | 0.61 | |||||
Tangible Book Value, 3 Yr. CAGR % | 12.22 | -26.92 | -17.81 | -17.54 | 31.17 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.66 | 1.35 | -4.61 | -10.96 | 9.45 | |||||
Capital Expenditures, 3 Yr. CAGR % | 22.53 | 29.07 | 15.02 | 1.36 | -24.61 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -10.24 | -49.62 | 25.25 | -28.68 | 23.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -9.33 | 15.62 | 24.84 | -22.24 | 22.34 | |||||
Dividend Per Share, 3 Yr. CAGR % | 16.04 | 11.87 | 12.71 | 12.29 | 8.13 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.28 | 9.14 | 11.55 | 13.33 | 12.66 | |||||
Gross Profit, 5 Yr. CAGR % | 9.16 | 9.85 | 10.84 | 10.27 | 9.16 | |||||
EBITDA, 5 Yr. CAGR % | 15.12 | 17.21 | 4.58 | 8 | -0.43 | |||||
EBITA, 5 Yr. CAGR % | 15.55 | 17.75 | 4.24 | 7.79 | -0.99 | |||||
EBIT, 5 Yr. CAGR % | 16.04 | 18.31 | 4.23 | 8.01 | -0.95 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 21.42 | 36.73 | 2.74 | 8.1 | -14.82 | |||||
Net Income, 5 Yr. CAGR % | 21.42 | 36.72 | 2.77 | 8.14 | -14.92 | |||||
Normalized Net Income, 5 Yr. CAGR % | 16.44 | 15.59 | 3.33 | 6.25 | -9.58 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 24.56 | 40.98 | 5.61 | 10.46 | -13.07 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 15.2 | 20.04 | 18.72 | 15.33 | 4.71 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.4 | 7.22 | 14.41 | 14.93 | 20.69 | |||||
Total Assets, 5 Yr. CAGR % | 7.22 | 11.8 | 9.64 | 13.12 | 9.84 | |||||
Common Equity, 5 Yr. CAGR % | 5.82 | 8.52 | 9.24 | 9.86 | 6.35 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.89 | -19.92 | -7.01 | -3.57 | -7.74 | |||||
Cash From Operations, 5 Yr. CAGR % | 45.39 | 3.16 | 2.52 | 12.87 | -10.91 | |||||
Capital Expenditures, 5 Yr. CAGR % | 13.01 | 20.09 | 16.41 | 10.41 | -4.82 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -1.63 | -53.25 | 9.25 | 21.05 | -10.59 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -1.02 | -33.04 | 9.32 | 46.92 | -18.15 | |||||
Dividend Per Share, 5 Yr. CAGR % | 16.8 | 19.27 | 14.51 | 12.1 | 9.98 |
- Stock Market
- Equities
- HUM Stock
- Financials Humana Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition